Sanofi-Aventis
Registered Principal Details
Business Or Interest:
Pharmaceutical Manufacturing.
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Chris Viehbacher
Vice President
Pharmaceutical Manufacturing.
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Chris Viehbacher
Vice President
Contact
JD
Joseph Devaney
55 Corporate Drive, Mail Stop 55B-230C
Bridgewater, NJ 08807-5925
(908) 981-4988
joseph.devaney@sanofi-aventis.com
www.sanofi-aventis.us
55 Corporate Drive, Mail Stop 55B-230C
Bridgewater, NJ 08807-5925
(908) 981-4988
joseph.devaney@sanofi-aventis.com
www.sanofi-aventis.us
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|
Lobbying Interests
Legislative Bills/Resolutions
January 2011 Special Session Senate Bill 1
Relating to: limiting noneconomic damages awarded in actions against long-term care providers; actions against manufacturers, distributors, sellers, and promoters of certain products; confidentiality of health care services reviews; use as evidence of info...
Bill Text and History
2011 Wisconsin Act 2
1/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: limiting noneconomic damages awarded in actions against long-term care providers; actions against manufacturers, distributors, sellers, and promoters of certain products; confidentiality of health care services reviews; use as evidence of info...
Bill Text and History
2011 Wisconsin Act 2
For
Notification Date1/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 276
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
Bill Text and History
10/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
Bill Text and History
For
Notification Date10/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Joint Resolution 73
Relating to: proclaiming November 2011 as pancreatic cancer awareness month.
Bill Text and History
11/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: proclaiming November 2011 as pancreatic cancer awareness month.
Bill Text and History
For
Notification Date11/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 101
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
5/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
5/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
Bill Text and History
For
Notification Date5/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Other
Notification Date5/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 204
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
Bill Text and History
2011 Wisconsin Act 85
10/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
Bill Text and History
2011 Wisconsin Act 85
For
Notification Date10/4/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Assembly Bill 21
Relating to: creation of the Wisconsin Next Generation Reserve Board and Wisconsin next generation reserve fund, authorizing the State of Wisconsin Investment Board to provide certain advice, services, and facilities to state agencies and others, requiring...
Bill Text and History
10/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: creation of the Wisconsin Next Generation Reserve Board and Wisconsin next generation reserve fund, authorizing the State of Wisconsin Investment Board to provide certain advice, services, and facilities to state agencies and others, requiring...
Bill Text and History
For
Notification Date10/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Support of LRB 1617/1, LRB 2878/1 epinephrine right to carry
Support of LRB 1617/1, LRB 2878/1 epinephrine right to carry
Action Intended To Affect
Legislative Matter
Notification Date
9/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
9/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Matters relating to medication administration
Matters relating to medication administration
Action Intended To Affect
Legislative Matter
Notification Date
1/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/22/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Academic detailing of pharmaceuticals
Academic detailing of pharmaceuticals
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Cancer Compendia
Cancer Compendia
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medical assistance in state budget
Medical assistance in state budget
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
pharmaceuticals advertising
pharmaceuticals advertising
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Related to prescription drug education, marketing, and dissemination of required information
Related to prescription drug education, marketing, and dissemination of required information
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Revision of oncology reference compendia
Revision of oncology reference compendia
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2011 January - June $21,172.91 |
2011 July - December $21,700.01 |
2012 January - June $21,425.46 |
2012 July - December $0.00 |
Total $64,298.38 |
Total Hours Communicating | 2011 January - June 36.50 |
2011 July - December 32.50 |
2012 January - June 16.50 |
2012 July - December 0.00 |
Total 85.50 |
Total Hours Other | 2011 January - June 16.50 |
2011 July - December 12.50 |
2012 January - June 7.00 |
2012 July - December 0.00 |
Total 36.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 10% |
2011 July - December 10% |
2012 January - June 15% |
2012 July - December |
Total 12% |
Relating to: limiting noneconomic damages awarded in actions against long-term care providers; actions against manufacturers, distributors, sellers, and promoters of certain products; confidentiality of health care services reviews; use as evidence of information regarding health care providers; reporting of quality indicators identifying individual hospitals; homicide or injury by negligent handling of a dangerous weapon, explosives, or fire; criminal abuse of individuals at risk; criminal abuse and neglect of patients and residents; evidence of lay and expert witnesses; damages for frivolous claims; and punitive damage awards.
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 15% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 7% |
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December 20% |
2012 January - June 15% |
2012 July - December |
Total 11% |
Relating to: allowing certain pupils to possess and use an epinephrine auto-injector.
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December 20% |
2012 January - June |
2012 July - December |
Total 7% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 5% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 2% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 5% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 2% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 5% |
2011 July - December |
2012 January - June 15% |
2012 July - December |
Total 5% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 10% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 4% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 10% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 4% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 15% |
2011 July - December 15% |
2012 January - June 40% |
2012 July - December |
Total 20% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 25% |
2011 July - December |
2012 January - June 15% |
2012 July - December |
Total 14% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.